Your browser doesn't support javascript.
loading
Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study.
Ladoire, Sylvain; Goussot, Vincent; Redersdorff, Emilie; Cueff, Adele; Ballot, Elise; Truntzer, Caroline; Ayati, Siavoshe; Bengrine-Lefevre, Leila; Bremaud, Nathalie; Coudert, Bruno; Desmoulins, Isabelle; Favier, Laure; Fraisse, Cléa; Fumet, Jean-David; Hanu, Roxana; Hennequin, Audrey; Hervieu, Alice; Ilie, Silvia; Kaderbhai, Courèche; Lagrange, Aurélie; Martin, Nils; Mazilu, Irina; Mayeur, Didier; Palmier, Rémi; Simonet-Lamm, Anne-Laure; Vincent, Julie; Zanetta, Sylvie; Arnould, Laurent; Coutant, Charles; Bertaut, Aurélie; Ghiringhelli, François.
Afiliação
  • Ladoire S; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France; Research Platform in Biological Oncology, Georges François Leclerc Cancer Center, Dijon, France; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; University of Burgundy-Franche Comté, France. Electronic address: sl
  • Goussot V; Department of Pathology and Tumor Biology, Centre Georges François Leclerc, Dijon, France.
  • Redersdorff E; Clinical Research Center (CRC), Centre Georges François Leclerc, Dijon, France.
  • Cueff A; Methodology and Biostatistics Unit, Centre Georges François Leclerc, Dijon, France.
  • Ballot E; Research Platform in Biological Oncology, Georges François Leclerc Cancer Center, Dijon, France; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; Bioinformatic Core Facility Georges, François Leclerc Cancer Center, Dijon, France.
  • Truntzer C; Research Platform in Biological Oncology, Georges François Leclerc Cancer Center, Dijon, France; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; Bioinformatic Core Facility Georges, François Leclerc Cancer Center, Dijon, France.
  • Ayati S; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Bengrine-Lefevre L; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Bremaud N; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Coudert B; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Desmoulins I; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Favier L; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Fraisse C; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Fumet JD; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Hanu R; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Hennequin A; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Hervieu A; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Ilie S; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Kaderbhai C; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Lagrange A; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Martin N; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Mazilu I; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Mayeur D; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Palmier R; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Simonet-Lamm AL; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Vincent J; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Zanetta S; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Arnould L; Research Platform in Biological Oncology, Georges François Leclerc Cancer Center, Dijon, France; Department of Pathology and Tumor Biology, Centre Georges François Leclerc, Dijon, France.
  • Coutant C; University of Burgundy-Franche Comté, France; Department of Oncologic Surgery, Centre Georges François Leclerc, Dijon, France.
  • Bertaut A; Methodology and Biostatistics Unit, Centre Georges François Leclerc, Dijon, France.
  • Ghiringhelli F; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France; Research Platform in Biological Oncology, Georges François Leclerc Cancer Center, Dijon, France; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; University of Burgundy-Franche Comté, France.
Eur J Cancer ; 148: 359-370, 2021 05.
Article em En | MEDLINE | ID: mdl-33780664
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article